Alnylam Pharmaceuticals, Inc. Total Liabilities for the year ending December 31, 2024: USD 4.17 B

Alnylam Pharmaceuticals, Inc. Total Liabilities is USD 4.17 B for the year ending December 31, 2024, a 3.02% change year over year. Total liabilities are the total amount of a company's debts and other obligations.
  • Alnylam Pharmaceuticals, Inc. Total Liabilities for the year ending December 31, 2023 was USD 4.05 B, a 9.34% change year over year.
  • Alnylam Pharmaceuticals, Inc. Total Liabilities for the year ending December 31, 2022 was USD 3.70 B, a 21.26% change year over year.
  • Alnylam Pharmaceuticals, Inc. Total Liabilities for the year ending December 31, 2021 was USD 3.06 B, a 27.78% change year over year.
  • Alnylam Pharmaceuticals, Inc. Total Liabilities for the year ending December 31, 2020 was USD 2.39 B, a 149.97% change year over year.
Key Data
Date Total Liabilities Shareholders' Equity Cash and Short-Term Investments Receivables